Search PubMed⌕ Search

Biomedical subjects

N Kasai

Publications and source records attributed to N Kasai.

215 records · Page 12Linked to original sources
PubMed1967

Endotoxic glycolipid from a heptoseless mutant of Salmonella minnesota.

The endotoxin of a heptoseless mutant of Salmonella minnesota R595 was extracted with phenol-water. Most of this material was found distributed in the insoluble fraction of the extract. The results showed that the R595 endotoxin behaved as a lipid rather than as a lipopolysaccharide (LPS). The preparation, although it does not contain O-specific polysaccharides, does contain 2-keto-3-deoxyoctonic acid (KDO), hexosamine, and several other unidentified compounds. Therefore, the term "glycolipid" is used in this paper instead of lipopolysaccharide. The crude glycolipid fraction, which was soluble in a mixture of chloroform-methanol (8:2), was purified by a procedure including fractionation with organic solvents and by different-column chromatographic methods. Although a chromatographic fraction of the glycolipid showed homogeneity in most systems investigated, the presence of contaminants could not be excluded. Chemical analysis of the glycolipids showed the absence of hexoses and heptoses. Constituents which were found were hexosamine, KDO, fatty acids, and phosphorus, which showed a relatively simple chemical composition. Partial acidic hydrolysis of the glycolipid yielded hexosamine-phosphates, as described in "Lipid A" fractions of smooth LPS preparations. Thin-layer chromatography of the partially hydrolyzed glycolipid showed a pattern similar to "Lipid A" fractions of other strains. The biological activity of the glycolipid was at the same level as that of other gram-negative endotoxins. Pyrogenicity, Shwartzman reactivity, and chick embryo ld(50) values were as high or higher than those of purified Serratia marcescens endotoxin preparations, but mouse ld(50) measurements gave significantly lower results.

Amino Acids↗
PubMedDate not supplied

Effect of D-glucose on nitric oxide release from glomerular endothelial cells.

BACKGROUND: Altered glomerular production of nitric oxide (NO) may be involved in hyperfiltration in early diabetic nephropathy. However little is known as to the role of glomerular endothelial cells (GECs) in diabetic hyperfiltration and their ability to release NO in response to hyperglycemia. METHODS: Using an established cell line, we directly monitored NO release from GECs in response to various concentrations of D-glucose, D-mannitol, and L-arginine, an NO synthase (NOS) agonist. L-Arginine-induced NO release was examined in the cells pretreated for different periods up to 24 h with 10 or 30 mM D-glucose. We also measured serially the accumulation of nitrite, the stable metabolite of NO, produced by the cells incubated for up to 24 h under 10 or 30 mM D-glucose conditions in the presence or absence of the NOS inhibitor, L-NAME. RESULTS: Direct measurement of NO demonstrated that D-glucose, but not D-mannitol, stimulation resulted in a rapid and dose-dependent increase in NO release by the cells. However, L-arginine-induced NO release was attenuated significantly in the cells preincubated for more than 12 h with 30 mM D-glucose compared to 10 mM D-glucose. The L-NAME-inhibitable production of nitrite in the media was significantly increased 1.5--2.0-fold until 6 h after incubation with 30 mM D-glucose compared to 10 mM D-glucose. CONCLUSIONS: We conclude that D-glucose, but not D-mannitol, produces a rapid and dose-dependent increase in NO release, whereas exposure to high D-glucose for more than 12 h may blunt NOS activity and/or NO stability in the GECs. These observations may therefore be important for glomerular endothelial dysfunction induced by hyperglycemia that is still tentative and may have a role in diabetic nephropathy.

Analysis of Variance↗